$BIO Protocol has announced the launch of PEPTAI, with 20% of the total supply allocated to users staking BIO. On May 14, BlockBeats reported that the DeSci protocol Bio Protocol has officially launched the PEPTAI token on the Base blockchain, along with an AI Agent designed to autonomously assist in peptide drug discovery. Users can claim tokens directly through the Bio application. Holders of BIO tokens (veBIO stakers) will receive 20% of the total supply, distributed linearly over 6 months. The 20% allocation can be redeemed at TGE, and early redemption will incur a penalty fee on the unredeemed portion. According to GMGN data, PEPTAI’s market capitalization surged to over $15 million within just 5 minutes of launch, and is currently trading around $13.5 million with a trading volume of $2.2 million. BlockBeats reminds users that token prices are highly volatile, and investments should be made with caution. #MarketOverloadWeek #SchwabCryptoGoesLive #SamsungLaborTalksCollapse